Immucor, Inc. - Strategic SWOT Analysis Review

Document Sample
Immucor, Inc. - Strategic SWOT Analysis Review Powered By Docstoc
					                                 Immucor, Inc. - Strategic SWOT Analysis Review
        Reference Code: GDME318SA                                                                                            Publication Date: SEP 2012

          3130 Gateway Drive, P.O Box 5625                   Phone             +1 770 4412051                   Revenue         336.7 (million USD)
          Norcross, GA                                       Fax               +1 770 4413807                   Net Profit      NA
          300915625                                          Website           www.immucor.com                  Employees       819
          United States                                      Exchange                                           Industry        Medical Equipment

       Company Overview
       Immucor, Inc. (Immucor) is a global in-vitro diagnostics which specializes in the area of pre-transfusion diagnostics. The company
       is involved in the development, production and sale of a full line of reagents and automated systems. The company develops
       products that are used in performing the tests to detect and identify certain properties of the cell and serum components of
       human blood before the process of blood transfusion. Its key customers include hospitals, clinical laboratories and blood banks.
       Immucor also provides fully automated instruments for daily function of blood banks, transfusion laboratories and small- and
       medium-sized hospitals.
       Key Executives                                                             SWOT Analysis
                     Name                                Title                     Immucor, Inc., SWOT Analysis
         William A Hawkins                 Chief Executive Officer                 Strengths                            Weaknesses
         Jeffrey K. Rhodes                 Director
                                                                                   Strong Research and                  Dependence on the US Market
         Todd B. Sisitsky                  Director                                Development Activities
                                                                                                                        Equity Financing
         Scott Garrett                     Director
                                                                                   Proprietary Technologies
         David A. Kessler                  Director                                Platforms
        Source: Company Website, Primary and Secondary Research,
        GlobalData
                                                                                   Opportunities                        Threats
        Key Competitors                                                            Transforming Transfusion             Changing Diagnostic Market
         Amgen Inc.                                                                Diagnostics                          Conditions
         Biogen Idec Inc.                                                          Growing In Vitro Diagnostics         Competitive Landscape
         Johnson & Johnson                                                         Market
         Ortho-Clinical Diagnostics Inc.
        Bio-Rad Laboratories, Inc.                                                Source: Company Website, Primary and Secondary Research, GlobalData
        Source: Company Website, Primary and Secondary Research,
        GlobalData


       Recent Developments

       Oct 06, 2011                  Immucor Appoints William A Hawkins As CEO
       Jul 05, 2011                  Faruqi & Faruqi Announces Investigation On Immucor
       Jun 12, 2011                  Immucor Announces Executive Changes
       Apr 14, 2011                  Immucor Announces Resignation Of Geoffrey Crouse As COO
       Apr 06, 2011                  Immucor Reports Net Sales Of $83.3m In Q3 Fiscal Year Ended 2011
       Source: Annual Report, Company Website, Primary and Secondary Research, GlobalData




Immucor, Inc. - Strategic SWOT Analysis Review                                                                                    Reference Code: GDME318SA
Source : www.globalcompanyintelligence.com                                                                                                              Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Immucor, Inc. - Key Facts................................................................................................................................................................... 4
       Immucor, Inc. - Key Employees.......................................................................................................................................................... 5
       Immucor, Inc. - Key Employee Biographies........................................................................................................................................ 6
       Immucor, Inc. - Major Products and Services ..................................................................................................................................... 7
       Immucor, Inc. - Medical Equipment Pipeline Products Data ............................................................................................................... 8
          Immucor, Inc. Pipeline Products by Equipment Type ..................................................................................................................... 8
          Immucor, Inc. Pipeline Products by Development Stage .............................................................................................................. 10
       Immucor, Inc. - History ..................................................................................................................................................................... 12
       Immucor, Inc. - Company Statement ................................................................................................................................................ 13
       Immucor, Inc. - Locations And Subsidiaries ..................................................................................................................................... 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Immucor, Inc. - Key Manufacturing Facilities .................................................................................................................................... 17
       Section 2 – Company Analysis ......................................................................................................................................................... 18
       Immucor, Inc. - Business Description ............................................................................................................................................... 18
       Immucor, Inc. - Corporate Strategy .................................................................................................................................................. 20
       Immucor, Inc. - SWOT Analysis ....................................................................................................................................................... 21
          SWOT Analysis - Overview........................................................................................................................................................... 21
          Immucor, Inc. - Strengths.............................................................................................................................................................. 21
             Strength - Strong Research and Development Activities........................................................................................................... 21
             Strength - Proprietary Technologies Platforms.......................................................................................................................... 21
             Strength - Strong Performance of Reagents Product Line ........................................................................................................ 21
          Immucor, Inc. - Weaknesses ........................................................................................................................................................ 22
             Weakness - Dependence on the US Market ............................................................................................................................. 22
             Weakness - Equity Financing .................................................................................................................................................... 22
             Weakness - Fall in Growth Ratios ............................................................................................................................................. 22
          Immucor, Inc. - Opportunities.........................................................................................
				
DOCUMENT INFO
Description: Immucor, Inc. (Immucor) is a global in-vitro diagnostics which specializes in the area of pre-transfusion diagnostics. The company is involved in the development, production and sale of a full line of reagents and automated systems. The company develops products that are used in performing the tests to detect and identify certain properties of the cell and serum components of human blood before the process of blood transfusion. Its key customers include hospitals, clinical laboratories and blood banks. Immucor also provides fully automated instruments for daily function of blood banks, transfusion laboratories and small- and medium-sized hospitals. The company's research and development continuously focuses on automation to improve blood bank operations and patient safety. The company operates in the US, Canada, Europe and Japan. The company operates through its subsidiaries and it has manufacturing facilities in U.S. and Canada. Immucor is headquartered in Georgia, the US.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.